Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Johanna Lehtomäki, Anne Nikkonen, Laura Merras-Salmio, Pauliina Hiltunen & Kaija-Leena Kolho. (2022) Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 57:1, pages 31-36.
Read now
Read now
Tero Ylisaukko-oja, Jaakko Aaltonen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Kimmo Salminen, Veikko Moilanen, Kalle Hakala, Mikko Kellokumpu, Kari Toljamo, Henna Rautiainen, Juha Kuisma, Markku Peräaho, Pauliina Molander, Jouni Silvennoinen, Ville Liukkonen, Hans Henricson, Jyrki Tillonen, Mirva Esterinen, Christian Nielsen, Eija Hirsi, Margus Lääne, Ulla-Maija Suhonen, Ilkka Vihriälä, Petri Mäkelä, Mika Puhto, Jari Punkkinen, Hannu Sulonen, Sauli Herrala, Jari Jokelainen, Klaus Tamminen & Taina Sipponen. (2018) High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO). Scandinavian Journal of Gastroenterology 53:2, pages 158-167.
Read now
Read now
Maureen C. Turina, Robert Landewé & Dominique Baeten. (2017) Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA. Expert Review of Clinical Immunology 13:4, pages 333-344.
Read now
Read now
Natalie E Walsham & Roy A Sherwood. (2016) Fecal calprotectin in inflammatory bowel disease. Clinical and Experimental Gastroenterology 9, pages 21-29.
Read now
Read now
Kaija-Leena Kolho & Antti Ainamo. (2016) Progress in the treatment and outcome of pediatric inflammatory bowel disease patients. Expert Review of Clinical Immunology 12:12, pages 1337-1345.
Read now
Read now
Taina Sipponen & Kaija-Leena Kolho. (2015) Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 74-80.
Read now
Read now
Articles from other publishers (23)
Maria Hemming-Harlo, Laura Merras-Salmio, Anne Nikkonen & Kaija-Leena Kolho. (2023) Drug levels of VEDOLIZUMAB in patients with pediatric-onset inflammatory bowel disease in a real-life setting. European Journal of Pediatrics.
Crossref
Crossref
Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava & Marion M. Aw. (2023) Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations. Journal of Gastroenterology and Hepatology 38:4, pages 510-522.
Crossref
Crossref
Marleen Bouhuys, Willem S Lexmond, Gerard Dijkstra, Triana Lobatón, Edouard Louis, Stephanie van Biervliet, Henk Groen, Jordi Guardiola & Patrick van Rheenen. (2021) Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial. BMJ Open 11:11, pages e054154.
Crossref
Crossref
Nan Wu, Cassandra Mah, Sabrina Koentgen, Leo Zhang, Michael C. Grimm, Emad El-Omar & Georgina L. Hold. (2021) Inflammatory bowel disease and the gut microbiota. Proceedings of the Nutrition Society 80:4, pages 424-434.
Crossref
Crossref
Patrick F van Rheenen, Marina Aloi, Amit Assa, Jiri Bronsky, Johanna C Escher, Ulrika L Fagerberg, Marco Gasparetto, Konstantinos Gerasimidis, Anne Griffiths, Paul Henderson, Sibylle Koletzko, Kaija-Leena Kolho, Arie Levine, Johan van Limbergen, Francisco Javier Martin de Carpi, Víctor Manuel Navas-López, Salvatore Oliva, Lissy de Ridder, Richard K Russell, Dror Shouval, Antonino Spinelli, Dan Turner, David Wilson, Eytan Wine & Frank M Ruemmele. (2021) The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. Journal of Crohn's and Colitis 15:2, pages 171-194.
Crossref
Crossref
Kaija-Leena Kolho. (2021) Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease. Frontiers in Pediatrics 8.
Crossref
Crossref
Anne Nikkonen & Kaija‐Leena Kolho. (2019) Infliximab and its biosimilar produced similar first‐year therapy outcomes in patients with inflammatory bowel disease. Acta Paediatrica 109:4, pages 836-841.
Crossref
Crossref
Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils & Séverine Vermeire. (2019) Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 68:6, pages 847-853.
Crossref
Crossref
Christopher Ma, Robert Battat, Reena Khanna, Claire E. Parker, Brian G. Feagan & Vipul Jairath. (2019) What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?. Best Practice & Research Clinical Gastroenterology 38-39, pages 101602.
Crossref
Crossref
Ivana Copova, Ondrej Hradsky, Kristyna Zarubova, Lucie Gonsorcikova, Kristyna Potuznikova, Tereza Lerchova, Jiri Nevoral & Jiri Bronsky. (2018) Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease. European Journal of Pediatrics 177:11, pages 1685-1693.
Crossref
Crossref
Dan Turner, Frank M. Ruemmele, Esther Orlanski-Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas-López, David C. Wilson, Sally Lawrence & Richard K. Russell. (2018) Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 67:2, pages 257-291.
Crossref
Crossref
E Nissilä, K Korpela, A I Lokki, R Paakkanen, S Jokiranta, W M de Vos, M-L Lokki, K-L Kolho & S Meri. (2017)
C4B
gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease
. Clinical and Experimental Immunology 190:3, pages 394-405.
Crossref
Crossref
Laura Merras-Salmio & Kaija-Leena Kolho. (2017) Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 64:2, pages 272-278.
Crossref
Crossref
Hana Manceau, Valérie Chicha-Cattoir, Hervé Puy & Katell Peoc’h. (2017) Fecal calprotectin in inflammatory bowel diseases: update and perspectives. Clinical Chemistry and Laboratory Medicine (CCLM) 55:4.
Crossref
Crossref
Laura Merras-Salmio & Kaija-Leena Kolho. (2016) Golimumab Therapy in Six Patients With Severe Pediatric Onset Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 63:3, pages 344-347.
Crossref
Crossref
Uri Kopylov & Ernest Seidman. (2016) Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 9:4, pages 513-526.
Crossref
Crossref
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch & Waliul Islam Khan. (2016) Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 51:5, pages 434-446.
Crossref
Crossref
Kaija-Leena Kolho, Riitta Paakkanen, Anna Lepistö, Annika Wennerstöm, Seppo Meri & Marja-Liisa Lokki. (2016) Novel Associations Between Major Histocompatibility Complex and Pediatric-onset Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 62:4, pages 567-572.
Crossref
Crossref
Kaija-Leena Kolho, Katri Korpela, Tytti Jaakkola, Madharasi V A Pichai, Erwin G Zoetendal, Anne Salonen & Willem M de Vos. (2015) Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation. American Journal of Gastroenterology 110:6, pages 921-930.
Crossref
Crossref
Shannon Chang. (2015) Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 21:40, pages 11246.
Crossref
Crossref
Frank S. Lehmann, Emanuel Burri & Christoph Beglinger. (2014) The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 8:1, pages 23-36.
Crossref
Crossref
Soo Yeon Choi, Ji Yeon Choi, Jeong Min Lee, Sanghyun Lee & Eun Ju Cho. (2015) Tartary buckwheat on nitric oxide-induced inflammation in RAW264.7 macrophage cells. Food & Function 6:8, pages 2664-2670.
Crossref
Crossref
Chian-Jiun Liou, Wen-Bin Len, Shu-Ju Wu, Chwan-Fwu Lin, Xin-Ling Wu & Wen-Chung Huang. (2014) Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. Journal of Ethnopharmacology 158, pages 310-316.
Crossref
Crossref